New IPO listings today: Discount or premium and gains? Vishal Nirmiti vs Nityas Gems - Check worst and best LiveMint · Markets 3m ago
Citi reiterates these 2 medtech stocks as its top picks in the sector Investing.com · Investing_news 16m ago
FDA accepts Bayer’s Kerendia filing for kidney disease without diabetes Investing.com · Investing_news 21m ago
Goldman Sachs upgrades Sonova stock on growth outlook, raises price target to CHF315 Investing.com · News 22m ago